Glucose-6-phosphate dehydrogenase deficiency
Toggle: English / Spanish
Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency is a hereditary condition in which red blood cells break down when the body is exposed to certain drugs or the stress of infection.
G-6-PD deficiency; Hemolytic anemia due to G6PD deficiency; Anemia - hemolytic due to G6PD deficiency
Causes, incidence, and risk factors
G6PD deficiency occurs when a person is missing or doesn't have enough of an enzyme called glucose-6-phosphate dehydrogenase, which helps red blood cells work properly.
Too little G6PD leads to the destruction of red blood cells. This process is called hemolysis. When this process is actively occurring, it is called a hemolytic episode. The episodes are usually brief, because the body continues to produce new red blood cells, which have normal activity.
Red blood cell destruction can be triggered by infections, severe stress, certain foods (such as fava beans), and certain drugs, including:
- Antimalarial drugs
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Sulfa drugs
Other chemicals, such as those in mothballs, can also trigger an episode.
In the United States, G6PD deficiency is more common among blacks than whites. Men are more likely to have this disorder than women.
You are more likely to develop this condition if you:
Are African American
Are of Middle Eastern decent, particularly Kurdish or Sephardic Jewish
Have a family history of the deficiency
A form of this disorder is common in whites of Mediterranean descent. This form is also associated with acute episodes of hemolysis. Episodes are longer and more severe than in the other types of the disorder.
Persons with this condition do not display any signs of the disease until their red blood cells are exposed to certain chemicals in food or medicine, or to stress.
Symptoms are more common in men and may include:
Signs and tests
A blood test can be done to check the level of G6PD. See: G6PD screen
Other tests that may be done include:
Treatment may involve:
Medicines to treat an infection, if present
Stopping any drugs that are causing red blood cell destruction
Transfusions, in some cases
Spontaneous recovery from a hemolytic episode is the usual outcome.
Rarely, kidney failure or death may occur following a severe hemolytic event.
Calling your health care provider
Call for an appointment with your health care provider if you have symptoms of this condition.
Call your health care provider if you have been diagnosed with G6PD deficiency and symptoms do not disappear after treatment.
Persons with G6PD deficiency must strictly avoid things that can trigger an episode. Talk to your health care provider about your medications.
Genetic counseling or testing may be available to those who have a family history of the condition.
Gregg XT, Prchal JT. Red blood cell enzymopathies. In: Hoffman R, Benz Jr. EJ, Shattil SJ, et al., eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Churchill Livingston; 2008:chap 45.
Golan DER. Hemolytic anemias: red cell membrane and metabolic defects. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 165.
- Last Reviewed on 03/28/2010
- David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2013 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
This page was last updated: May 31, 2013